热门资讯> 正文
前瞻性恢复纳斯达克合规性
2025-09-10 20:42
- Foresight Autonomous (NASDAQ:FRSX) received a letter from Nasdaq saying that it has regained compliance with the minimum bid price requirement under Nasdaq rule.
- The company was previously notified by Nasdaq on March 24, that it was not in compliance with the minimum bid price rule because its ADSs failed to meet the closing bid price of $1.00 or more for 30 consecutive business days.
- From August 25, 2025, through September 8, 2025, the closing bid price of the Company’s ADSs has been at $1.00 per ADS or greater.
More on Foresight Autonomous
- Seeking Alpha’s Quant Rating on Foresight Autonomous
- Historical earnings data for Foresight Autonomous
- Financial information for Foresight Autonomous
推荐文章
港股异动 | “港股通新宠”再次狂飙！截至发稿，佰泽医疗狂飙超62%，药捷安康-B大涨43%
新股首日 | “全球激光雷达龙头”禾赛-W涨逾7%！中签一手赚328港元
华盛早报 | 深夜大涨！谷歌市值突破3万亿美元大关；特朗普欲废除美股季报制度，改为仅披露半年报
9月16日外盘头条：马斯克增持10亿美元特斯拉股票 OpenAI推出新版GPT-5 特朗普敦促共和党团结 通过拨款法案
美股机会日报 | 特朗普怒斥：美联储主席能力不足！马斯克增持特斯拉后股价狂飙超8%
“三重利好”点燃特斯拉股价情绪！马斯克押宝Optimus机器人量产，这些概念也要爆？
新股暗盘 | “全球激光雷达龙头”禾赛-W涨近6%，中签一手账面浮盈248港元
港股异动 | 药捷安康上市不到3个月飙升超2000%，市值升破1100亿港元
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
